Am J Physiol Cell Physiol Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 280: C441-C450, 2001;
0363-6143/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (76)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, E. D.
Right arrow Articles by Riches, D. W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, E. D.
Right arrow Articles by Riches, D. W. H.
Vol. 280, Issue 3, C441-C450, March 2001

IFN-gamma  + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line

Edward D. Chan1 and David W. H. Riches2

1 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, and 2 Program in Cell Biology, National Jewish Medical and Research Center, Denver, Colorado 80206

Nitric oxide (NO·) produced by inducible nitric oxide synthase (iNOS) mediates a number of important physiological and pathophysiological processes. The objective of this investigation was to examine the role of mitogen-activated protein kinases (MAPKs) in the regulation of iNOS and NO· by interferon-gamma (IFN-gamma ) + lipopolysaccharide (LPS) in macrophages using specific inhibitors and dominant inhibitory mutant proteins of the MAPK pathways. The signaling pathway utilized by IFN-gamma in iNOS induction is well elucidated. To study signaling pathways that are restricted to the LPS-signaling arm, we used a subclone of the parental RAW 264.7 cell line that is unresponsive to IFN-gamma alone with respect to iNOS induction. In this RAW 264.7gamma NO(-) subclone, IFN-gamma and LPS are nevertheless required for synergistic activation of the iNOS promoter. We found that extracellular signal-regulated kinase (ERK) augmented and p38mapk inhibited IFN-gamma  + LPS induction of iNOS. Dominant-negative MAPK kinase-4 inhibited iNOS promoter activation by IFN-gamma  + LPS, also implicating the c-Jun NH2-terminal kinase (JNK) pathway in mediating iNOS induction. Inhibition of the ERK pathway markedly reduced IFN-gamma  + LPS-induced tumor necrosis factor-alpha protein expression, providing a possible mechanism by which ERK augments iNOS expression. The inhibitory effect of p38mapk appears more complex and may be due to the ability of p38mapk to inhibit LPS-induced JNK activation. These results indicate that the MAPKs are important regulators of iNOS-NO· expression by IFN-gamma  + LPS.

nitric oxide; monocytes/macrophages; protein kinases; lipopolysaccharide; rodent


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. W. Jeong, K. C. Hsu, J.-W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E955 - E964.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Ghosh, J. Y. Park, C. Fenno, and Y. L. Kapila
Porphyromonas gingivalis, Gamma Interferon, and a Proapoptotic Fibronectin Matrix Form a Synergistic Trio That Induces c-Jun N-Terminal Kinase 1-Mediated Nitric Oxide Generation and Cell Death
Infect. Immun., December 1, 2008; 76(12): 5514 - 5523.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Schmidt, T. H. Westhoff, P. Krauser, R. Ignatius, J. Jankowski, V. Jankowski, W. Zidek, and M. van der Giet
The uraemic toxin phenylacetic acid impairs macrophage function
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3485 - 3493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. J. Calvert, L. G. Chicoine, Y. Liu, and L. D. Nelin
Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1621 - H1629.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Schmidt, T. H. Westhoff, P. Krauser, W. Zidek, and M. van der Giet
The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. A. Smith, J. S. Moylan, J. D. Smith, W. Li, and M. B. Reid
IFN-{gamma} does not mimic the catabolic effects of TNF-{alpha}
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1947 - C1952.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Uno, K. Kato, T. Atsumi, T. Suzuki, J. Yoshitake, H. Morita, S. Ohara, Y. Kotake, T. Shimosegawa, and T. Yoshimura
Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1004 - G1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. D. Nelin, X. Wang, Q. Zhao, L. G. Chicoine, T. L. Young, D. M. Hatch, B. K. English, and Y. Liu
MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C632 - C640.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Blanchette, P. Pouliot, and M. Olivier
Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation
J. Leukoc. Biol., March 1, 2007; 81(3): 835 - 844.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Y. Ma, R. S. Flanc, G. H. Tesch, Y. Han, R. C. Atkins, B. L. Bennett, G. C. Friedman, J.-H. Fan, and D. J. Nikolic-Paterson
A Pathogenic Role for c-Jun Amino-Terminal Kinase Signaling in Renal Fibrosis and Tubular Cell Apoptosis
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 472 - 484.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Forget, D. J. Gregory, L. A. Whitcombe, and M. Olivier
Role of Host Protein Tyrosine Phosphatase SHP-1 in Leishmania donovani-Induced Inhibition of Nitric Oxide Production.
Infect. Immun., November 1, 2006; 74(11): 6272 - 6279.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. M. Tiwari, K. J. Messer, and P. R. Mayeux
Inducible Nitric Oxide Synthase and Apoptosis in Murine Proximal Tubule Epithelial Cells
Toxicol. Sci., June 1, 2006; 91(2): 493 - 500.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y.-N. Zhu, Y.-F. Yang, S. Ono, X.-G. Zhong, Y.-H. Feng, Y.-X. Ren, J. Ni, Y.-F. Fu, W. Tang, and J.-P. Zuo
Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-{gamma} is associated with the activation of extracellular signal-related kinase
Int. Immunol., June 1, 2006; 18(6): 981 - 990.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Lim, D. C. Gowda, G. Krishnegowda, and S. Luckhart
Induction of Nitric Oxide Synthase in Anopheles stephensi by Plasmodium falciparum: Mechanism of Signaling and the Role of Parasite Glycosylphosphatidylinositols
Infect. Immun., May 1, 2005; 73(5): 2778 - 2789.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Wu, R. D. Mosteller, and D. Broek
Sphingosine Kinase Protects Lipopolysaccharide-Activated Macrophages from Apoptosis
Mol. Cell. Biol., September 1, 2004; 24(17): 7359 - 7369.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis
MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease
J. Immunol., August 1, 2004; 173(3): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Sumi and L. J. Ignarro
Regulation of Inducible Nitric Oxide Synthase Expression in Advanced Glycation End Product-Stimulated RAW 264.7 Cells: The Role of Heme Oxygenase-1 and Endogenous Nitric Oxide
Diabetes, July 1, 2004; 53(7): 1841 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Ikezumi, L. Hurst, R. C. Atkins, and D. J. Nikolic-Paterson
Macrophage-Mediated Renal Injury Is Dependent on Signaling via the JNK Pathway
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1775 - 1784.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume
Interferon-{gamma}: an overview of signals, mechanisms and functions
J. Leukoc. Biol., February 1, 2004; 75(2): 163 - 189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Lahti, U. Jalonen, H. Kankaanranta, and E. Moilanen
c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages
Mol. Pharmacol., August 1, 2003; 64(2): 308 - 315.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. R. Morris, R. D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E. D. Chan
Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide
Infect. Immun., March 1, 2003; 71(3): 1442 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H.-S. Choi, P. R. Rai, H. W. Chu, C. Cool, and E. D. Chan
Analysis of Nitric Oxide Synthase and Nitrotyrosine Expression in Human Pulmonary Tuberculosis
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Leoni, A. Zaliani, G. Bertolini, G. Porro, P. Pagani, P. Pozzi, G. Dona, G. Fossati, S. Sozzani, T. Azam, et al.
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
PNAS, March 5, 2002; 99(5): 2995 - 3000.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online